Abstract:Background: Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease characterized by immune mechanisms dysregulation, leading to the production of diverse autoantibodies. However, the immune pathways underlying B-cell function and phenotypic abnormalities related to SLE pathogenesis remain incompletely understood. Objective: To explore new markers of SLE activity and potential targets for SLE immunotherapy. Methods: Collect peripheral blood mononuclear cells (PBMCs) from SLE patients and healthy controls (HC). Use flow cytometry to detect CD39 and CD73 expression on B cell subsets and enzyme-linked immunosorbent assay (ELISA) to measure adenosine (ADO) concentrations in SLE patients' serum. Compare CD39+CD73+ B cell subsets frequency and ADO concentrations in SLE patients and HC group. Additionally, analyze the correlation between CD39+CD73+ B cell subsets frequency and clinical laboratory parameters. Results: CD39 and CD73 are simultaneously highly expressed on CD19+ B cell subsets, with significantly lower frequency of CD39+CD73+ B cell subsets in SLE patients compared to HC group. This frequency negatively correlates with Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), C-reactive protein (CRP), and anti-double-stranded DNA (anti-dsDNA) antibodies, while positively correlating with IgM and prothrombin time (PT). Additionally, the frequency of CD39+CD73+ B cell subsets is significantly negatively correlated with IL-6 and IFN-α. In vitro cell experiments demonstrate that adenosine significantly inhibits R848-induced inflammatory cytokine production in a dose-dependent manner. Conclusion: The frequency of CD39+CD73+ B cell subsets of SLE patients is decreased, correlating with clinical laboratory parameters and disease activity. Simultaneously, ADO concentration in the patients' serum is reduced. The CD39+CD73+ B cell/ADO pathway may represent a novel immunotherapy strategy for SLE.

The skewed frequency of B-cell subpopulation CD19 + CD24 hi CD38 hi cells in peripheral blood mononuclear cells is correlated with the elevated serum sCD40L in patients with active systemic lupus erythematosus.

Peripheral CD24hi CD27+ CD19+ B Cells Subset As a Potential Biomarker in Naïve Systemic Lupus Erythematosus.

Aberrant T Cell Subsets and Cytokines Expression Profile in Systemic Lupus Erythematosus.

Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus.

[Clinical Significance of CD4+CD25+ T Cells in Peripheral Blood of Patients in Systemic Lupus Erythematosus].

Abnormal Expression of Cd43 in Patients with Systemic Lupus Erythematosus and Its Clinical Significance

Aberrant CD200/CD200R1 Expression and Function in Systemic Lupus Erythematosus Contributes to Abnormal T-cell Responsiveness and Dendritic Cell Activity

Aberrant CD40-Induced NF-κB Activation in Human Lupus B Lymphocytes

lncRNA X-inactive-specific transcript is a potential biomarker related to changes in CD4 + T cell levels in systemic lupus erythematosus

Frequency and Significance of CD4+CD25+T Cell Subpopulations in the Peripheral Blood of Patients with Systemic Lupus Erythematosus

The reduced frequency of CD39+CD73+ B cell subsets in SLE patients is correlated with disease activity

Abnormal surface markers expression on bone marrow CD34 + cells and correlation with disease activity in patients with systemic lupus erythematosus

Altered Frequency of Peripheral B-cell Subsets and Their Correlation with Disease Activity in Patients with Systemic Lupus Erythematosus: A Comprehensive Analysis.

CD16+ Monocyte Subset Was Enriched and Functionally Exacerbated in Driving T-Cell Activation and B-Cell Response in Systemic Lupus Erythematosus

Higher CD4+CD40+ T cells (Th40 cells) associate with systemic lupus erythematosus activity

Decreased CD1d level is associated with CD86 over-expression in B cells from systemic lupus erythematosus.

Elevated CD19+Siglec-10+ B cell levels are correlated with systemic lupus erythematosus disease activity

Elevated Circulating Cd4(+)Icos(+)Foxp3(+) T Cells Contribute to Overproduction of Il-10 and Are Correlated with Disease Severity in Patients with Systemic Lupus Erythematosus

The study of the relationship between the changes of peripheral blood mononuclear cells expression of FcγR Ⅱb, serum sCD30 and the drift of Th1/Th2 cells in systemic lupus erythematosus patients

Change of CD4~+CD25~+ T regulatory cells in systemic lupus erythematosus

[Altered Frequency of CD4+CD25-Foxp3+ T Cells in Patients with Systemic Lupus Erythematosus].